← Leaderboards
Steven T. Sizemore
Ohio State University
$560,520
Attributed
$560,520
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $186.8K · FY2017–19$200K$150K$100K$50K$0
'17
'18
'19
Funding mix
By agency
NIH$560,520 · 1
By mechanism
K22$560,520 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Ming You$26,875,453
- Danilo Perrotti$4,143,140
- Raphael E. Pollock$16,802,076
- Kalpana Ghoshal$5,864,666
- Gina Marie Sizemore$1,951,429
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseAwardBaseBiologicalBiological ModelsBreast Cancer MetastasisCancer Research ProjectCell LineCellsCessation Of LifeClinicClinical ApplicationClinical PathwaysCohortCollaborative EnvironmentCollectionComplexComprehensive Cancer CenterCouplingDepartment Of DefenseDoctor Of PhilosophyDrug TargetingEffectivenessAdult
Grant awards (3)
Determining the role of RALA and RALB in soft tissue sarcoma tumor growth and metastasis$186,840
K22 · FY2019 · CA · contact PI
Determining the role of RALA and RALB in soft tissue sarcoma tumor growth and metastasis$186,840
K22 · FY2018 · CA · contact PI
Determining the role of RALA and RALB in soft tissue sarcoma tumor growth and metastasis$186,840
K22 · FY2017 · CA · contact PI